2015•Unpublished venueRequires access
The current endocrine therapy for breast cancer
Juanjuan Wang, Li Jian, Yuan Chai, Bin Liu
Open publisher page 0 citations
Abstract
Endocrine therapy forms a central modality in the treatment of estrogen receptor positive breast cancer. The endocrine therapy for breast cancer has made progress with the development of new endocrine drugs. Now, tamoxifen is still the standard endocrine therapeutic drug for the premenopausal patients, but aromatase inhibitors can bring more clinical effect for the postmenopausal patients. This review details the current endocrine therapy utilized in breast cancer.